Immunology

Catch up on EADV 2026 poster highlights: real-world dupilumab data in atopic dermatitis, bullous pemphigoid and prurigo nodularis. For healthcare professionals.

Explores the connections between Type 2 inflammatory diseases and the opportunities to improve patient outcomes through earlier, targeted intervention

Access ERS 2026 Congress highlights on severe asthma, COPD, and biologic therapies. Real-world evidence and clinical insights for HCPs

Explore ATS 2026 key sessions on dupilumab, COPD biologics, FeNO biomarkers, and asthma remission. Real-world evidence for HCPs

AAD 2026 post-congress: Complete systemic therapy update. Multi-indication clinical data for inflammatory dermatological conditions.

The programme brought together international and local experts to discuss the evolving understanding of Type 2 inflammation in atopic dermatitis, with a focus on IL-4 and IL-13, disease modification, and the importance of early intervention across different patient populations. 

Access the full recording of the webinar to gain insights on Atopic Dermatitis, Bullous Pemphigoid, and practical applications from leading experts.

Watch now to gain useful update on the latest in COPD diagnosis and management.​